The connection was traced through a growth -
factor gene mutation not seen in larger dogs.
Not exact matches
A total of 150 women with a history of two or more recurrent miscarriages and 20 fertile control women with no history of pregnancy losses had buccal swabs taken for DNA analyses of 10
gene mutations [
factor V G1691A,
factor V H1299R (R2),
factor V Y1702C,
factor II prothrombin G20210A,
factor XIII V34L, beta - fibrinogen -455 G > A, PAI - 1 4G / 5G, HPA1 a / b (L33P), MTHFR C677T, MTHFR A1298C].
Because of either a genetic
mutation or environmental
factors that affect how the
gene directs the protein's development, some people's oxytocin receptors may be folded up in ways that prevent them from binding well to the hormone.
Disease - causing viruses engage their hosts in ongoing arms races: positive selection for antiviral
genes increases host fitness and survival, and viruses in turn select for
mutations that counteract the antiviral host
factors.
Page and his colleagues, who use animal models to understand how autism risk
factors impact the developing brain and to identify potential treatments for the condition, have found that animals with
mutations in the autism risk
gene phosphatase and tensin homolog (Pten) mimic aspects of autism, including increased brain size, social deficits and increased repetitive behavior.
Between 10 and 30 percent of NSCLC cases are driven by
mutations in the epidermal growth
factor receptor (EGFR)
gene.
Unlike other autoimmune disorders with associated risk
factors, APECED is clearly caused by a
mutation in a single
gene, based on analyses of affected families.
The good news is, unless you have one of the very rare genetic
mutations that undeniably cause obesity, your
genes are just one
factor in your weight profile.
Inherited
mutations of the tumour suppressor
gene CDKN2A are the strongest known risk
factors for familial melanoma and
mutations in this
gene also increase the risk of other cancers.
Mutation of this
gene, which leads to decreased GCase activity in the brain, has been found to be a genetic risk
factor for Parkinson's, although the majority of patients with Parkinson's do not carry
mutations in the Gaucher
gene.
When he delved into the genomes of those with a milder disease, he often saw not just a
mutation in the affected clotting -
factor gene, but also a
mutation in another
gene — the first causing haemophilia, the tendency to bleed, and the second causing thrombophilia, the tendency to clot.
Hockemeyer says that it's unlikely to be another
mutation, but rather an epigenetic change that affects expression of the telomerase
gene, or a change in the expression of a transcription
factor or other regulatory proteins that binds to the promoter upstream of the telomerase
gene.
Spalax naturally have a variant in the p53
gene (a transcription
factor and known tumor suppressor), which is identical to a cancer - related
mutation in humans, Band said.
Disease processes often begin with
mutations in the transcription
factor, or in the DNA they bind to inside the nucleus of cells to regulate the complex interplay of
genes needed for a healthy functioning body.
Among patients with advanced non-small cell lung cancer without a
mutation of a certain
gene (EGFR), conventional chemotherapy, compared with treatment using epidermal growth
factor receptor tyrosine kinase inhibitors, was associated with improvement in survival without progression of the cancer, but not with overall survival, according to a study in the April 9 issue of JAMA.
Epidermal growth
factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred treatment option for patients with advanced non-small cell lung cancer (NSCLC) who have
mutations in the EGFR
gene.
Patients with metastatic colorectal cancer (mCRC) that are
mutation - free in the KRAS, NRAS, BRAF and PIK3CA
genes showed significant benefit from continuing anti-epidermal growth
factor receptor (EGFR) therapy beyond progression following first - line chemotherapy and an anti-EGFR monoclonal antibody, according to study results (1) presented today at the ESMO 17th World Congress on Gastrointestinal Cancer in Barcelona, Spain.
Researchers at the San Diego Supercomputer Center (SDSC) and the Moores Cancer Center at the University of California, San Diego, have described for the first time the molecular mechanism of cancer development caused by well - known «resistance»
mutations in the
gene called epidermal growth
factor receptor (EGFR).
The researchers also identified specific
mutations in
genes important in adaptation to
factors such as climate and pathogens, including those involved in morphology, behaviour and innate immunity.
The new study — published October 18, 2016 in the journal Molecular Psychiatry — combined genetic analysis of more than 9,000 human psychiatric patients with brain imaging, electrophysiology, and pharmacological experiments in mutant mice to suggest that
mutations in the
gene DIXDC1 may act as a general risk
factor for psychiatric disease by interfering with the way the brain regulates connections between neurons.
Hereditary predisposition to cancer is sometimes due to a single high - risk genetic change, like a
mutation in the BRCA1 or BRCA2
genes for breast cancer, but most of the time, the disease is the result of multiple
gene variants that add up, environmental risk
factors, and a big element of chance.
The advent of therapies directed at tumors with
mutations in epidermal growth
factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and B - Raf proto - oncogene (BRAF)
genes over the past decade have dramatically changed outcomes, he says.
By combining those
factors, Phevor identifies an undiagnosed disease or the most likely candidate
gene mutation for causing a disease.
In addition, molecular studies of human colorectal cancer samples recently uncovered multiple
mutations in the TRPV1
gene, though Raz noted that currently there is no direct evidence that TRPV1 deficiency is a risk
factor for colorectal cancer in humans.
Mutations in the BRCA1
gene are one of the most common risk
factors for breast and ovarian cancers.
Specifically, this
mutation, which likely occurred very early in evolution after the separation of our group from that of sea anemones, affected a
gene of the Fgfr (fibroblast growth
factor receptors) family.
Professor Michael Lisanti, from The University of Manchester — part of Manchester Cancer Research Centre, said: «We know that high breast density can greatly increase a woman's breast cancer risk as well as other
factors such as aging, family history and presence of
mutations in
genes such as BRCA 1 and BRCA 2.
Genetic
factors are clearly indicated as evidenced by dominant
mutations in three different
genes have been identified that account for the small number of cases of familial, early - onset AD.
Alice Shaw recalls a signal moment in 2004 — just as she was finishing her oncology fellowship at MIT — when scientists discovered that
mutations in a
gene for epidermal growth
factor receptor (EGFR) were the culprits in about 10 to 15 percent of lung cancer patients.
Students in the UBC program engage in a wide range of research: molecular mechanisms underlying cell proliferation in cancer or cell death in stroke; relating
gene mutations to disease mechanisms; the social
factors that determine access to health care for women living on the street.
A
mutation in the
gene encoding fibroblast growth
factor receptor 3 (FGFR3) has been associated with two types of skeletal dysplasia, thanatophoric dysplasia (TD), a skeletal dysplasia that cause serious respiratory problems at birth and is often lethal, and achondroplasia (ACH), which causes stunted growth and other complications throughout life.
Washington State University researchers say environmental
factors are having an underappreciated effect on the course of disease and evolution by prompting genetic
mutations through epigenetics, a process by which
genes are turned on and off independent of an organism's DNA sequence.
Heterozygous missense
mutations of the NSMF (NMDA receptor synaptonuclear signaling and neuronal migration
factor, also known as NELF)
gene have been associated with Kallmann syndrome.
PULLMAN, Wash. — Washington State University researchers say environmental
factors are having an underappreciated effect on the course of disease and evolution by prompting genetic
mutations through epigenetics, a process by which
genes are turned on and off independent of an organism's DNA sequence.
An Open Label, Phase II Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth
Factor Receptor (EGFR, HER2, HER3)
Mutations or EGFR
Gene Amplification
Are any risk
factors (e.g.,
gene mutations, environmental exposures) common among people who develop a certain kind of cancer?
Recent evidence has suggested that epigenetic
factors may regulate
genes associated with diabetic complications, but without permanently altering the underlying DNA itself, as would happen in a genetic
mutation.
The researchers, mathematician Cristian Tomasetti and cancer geneticist Bert Vogelstein, both of Johns Hopkins University, set out to determine what proportion of cancer
mutations are due to unpredictable DNA - copying errors — as opposed to the two other main contributors to cancer, inherited
genes and environmental
factors, such as smoking and obesity.
One such regulatory protein is called complement
factor H, and
mutations in its
gene are associated with AMD.
Working with Nancy Cox, PhD, professor of medicine and human genetics and section chief of genetic medicine at the University of Chicago, Bell discovered
mutations in the
genes for glucokinase and for three transcription
factors that cause an early - onset form of diabetes called maturity - onset diabetes of the young.
A specific codon (34) in U2AF1 harbored missense
mutations in multiple AML tumors, suggesting a gain - of - function for the splicing
factor encoded by that
gene.
The researchers found that patients from MODY3 families had one of several different
mutations in the
gene for hepatocyte nuclear
factor 1 alpha (HNF -1-alpha) but healthy subjects had normal copies of the
gene.
Recent genetic research in humans has implicated
mutations in the
gene for Tet2 as a risk
factor for many different diseases of aging, including cancer, cardiovascular disease, and stroke.
Mutations in the beta - catenin
gene, or flaws in the
factors that degrade it, have long been linked to more aggressive disease in various tumor types, including colon, lung and prostate cancer, and melanoma.
The mice in the study had
mutations in a
gene called KL2 (for c - kit ligand 2) in their Sertoli cells, cells in the testis that aid in sperm cell development by providing structural support and growth
factors.
For example, mutants may be characterized by comparing their transcript profiles to those obtained in other experiments querying the effects on
gene expression of many experimental
factors including treatments,
mutations and pathogen infections.
The American Cancer Society has a page about genetic risk
factors for breast cancer, including the BRCA and other
gene mutations.
stem cell therapy for ischemic cardiovascular disease; Molecular mechanisms of oxygen homeostasis; Genetic syndromes due to
mutations in
genes encoding transcription
factors
In the multivariate analysis, when the International Prognostic Index was controlled for, the presence of a histone modifier
gene mutation was an independent prognostic
factor for progression - free survival (P < 0.001)(Table 1).
Other projects focus on studying how
mutations found in the
genes for skeletogenic transcription
factors cause skeletal and other defects in human patients and finding ways to overcome the negative effects of these
mutations in patients.